Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. [electronic resource]
Producer: 20040420Description: 123-32 p. digitalISSN:- 0903-4641
- Breast Neoplasms -- enzymology
- Carcinoma in Situ -- enzymology
- Carcinoma, Ductal -- enzymology
- Carcinoma, Lobular -- enzymology
- Female
- Humans
- Immunohistochemistry
- NF-kappa B -- metabolism
- Neoplasm Recurrence, Local -- pathology
- Proliferating Cell Nuclear Antigen -- metabolism
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Survival Analysis
- Thioredoxin-Disulfide Reductase -- biosynthesis
- Thioredoxins -- biosynthesis
- Tumor Suppressor Protein p53 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.